Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Churg-Strauss Syndrome

• A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
• Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
• Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
• Hydroxychloroquine in ANCA Vasculitis Evaluation
• Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
• Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
• Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.
• Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
• Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
• Rituximab in Eosinophilic Granulomatosis With Polyangiitis
• A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
• Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
• Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome
• Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
• Rituxan in Churg Strauss Syndrome With Renal Involvement
• CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors
• Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
• RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
• Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases